Evaluation of bacterial uptake, antibacterial efficacy against <i>Escherichia coli</i>, and cytotoxic effects of moxifloxacin-loaded solid lipid nanoparticles.

Kiymaci, Merve Eylul; Topal, Gizem Ruya; Esim, Ozgur; Bacanli, Merve; Ozkan, Cansel Kose; Erdem, Onur; Savaser, Ayhan; Ozkan, Yalcin

Evaluation of bacterial uptake, antibacterial efficacy against Escherichia coli, and cytotoxic effects of moxifloxacin-loaded solid lipid nanoparticles.

Kiymaci, Merve Eylul; Topal, Gizem Ruya; Esim, Ozgur; Bacanli, Merve; Ozkan, Cansel Kose; Erdem, Onur; Savaser, Ayhan; Ozkan, Yalcin.

Afiliación

Kiymaci ME; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Ankara, Turkey.
Topal GR; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Biotechnology, Ankara, Turkey.
Esim O; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey.
Bacanli M; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara, Turkey.
Ozkan CK; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey.
Erdem O; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara, Turkey.
Savaser A; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey.
Ozkan Y; University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey.

Arh Hig Rada Toksikol ; 73(4): 260-269, 2022 Dec 01.

Article en En | MEDLINE | ID: mdl-36607722

Asunto(s)

Antineoplásicos; Nanopartículas; Moxifloxacino/farmacología; Escherichia coli; Portadores de Fármacos; Nanopartículas/toxicidad; Antibacterianos/toxicidad; Lípidos

Palabras clave

E. coli; RAW 264.7 cell line; antibiotic; antibiotik; biocompatibility; biokompatibilnost; drug resistance; lipid-based nanoparticles; nanocestice s lipidima; rezistentnost na lijek; stanicna linija RAW 264.7

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Antineoplásicos Idioma: En Revista: Arh Hig Rada Toksikol Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Croacia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google